{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:40:55Z","timestamp":1761676855929},"reference-count":43,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,7,3]]},"DOI":"10.1080\/17446651.2020.1773259","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T18:28:12Z","timestamp":1590172092000},"page":"217-226","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["New testosterone 2% gel using Ferring Advanced Skin Technology (FAST), for the treatment of testosterone deficiency in men, with a novel applicator"],"prefix":"10.1080","volume":"15","author":[{"given":"Michael","family":"Kirby","sequence":"first","affiliation":[{"name":"Editor Trends in Urology & Men's Health, John Wiley & Sons, The Atrium, Chichester, West Sussex"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Kalhan","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Royal Glamorgan Hospital, Llantrisant, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Hackett","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Aston University Medical School, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"cit0001","unstructured":"Dohle GH, Arver S, Bettocchi C, et al. Guidelines on male hypogonadism. European Association of Urology; 2019 [cited 2020 Feb 26]. Available from: https:\/\/uroweb.org\/guideline\/male-hypogonadism\/"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12952"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/andr.274"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12487"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30254-2"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911101"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1245"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.122336"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1796"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2016.11.16"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.10.009"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.10.067"},{"key":"cit0013","first-page":"71","author":"Hackett G","year":"2017","journal-title":"Int J Clin Pract"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.3109\/13685538.2015.1004049"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-019-00627-7"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1310\/hpj5109-712"},{"key":"cit0017","first-page":"101","volume":"8","author":"Ullah M","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/625434"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.110"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0221"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.11.225"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12114"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1902"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/and.12493"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.4158\/EP161665.OR"},{"key":"cit0026","first-page":"e12801","author":"Belkoff L","year":"2017","journal-title":"Andrologia"},{"key":"cit0027","unstructured":"Testavan patient information leaflet. 2018 Feb [cited 2019 Oct 09]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/9489\/pil"},{"key":"cit0028","unstructured":"Testavan summary of product characteristics. 2018 Feb [cited 2019 Oct 09]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/9489\/smpc"},{"key":"cit0029","unstructured":"Food and Drug Administration. UFaD testosterone products: FDA\/CDER statement-risk of venous blood clots. 2014 [cited 2020 Feb 26]. Available from: https:\/\/wayback.archive-it.org\/7993\/20170406123836\/https:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm402054.htm"},{"key":"cit0030","unstructured":"US Food and Drug Administration (online). FDA DRUG SAFETY COMMUNICATION: FDA cautions about using testosterone products for low testosterone due to aging; required labeling change to inform of possible increased risk of heart attack and stroke with use. 2015 [cited 2020 Feb 25]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.5135"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010011"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.03.115"},{"key":"cit0035","unstructured":"T4DM trial. [cited 2019 Nov 04]. Available from: http:\/\/www.t4dm.org.au\/"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/816740"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.4103\/iju.IJU_372_16"},{"key":"cit0038","unstructured":"Healio Endocrine Today (online). Low-dose hCG can prevent sterility in men prescribed testosterone. 2019 Mar 23 [cited 2019 Nov 04]. Available from: https:\/\/www.healio.com\/endocrinology\/reproduction-androgen-disorders\/news\/online\/%7B027a4c7b-74f0-4f3a-a30f-0c24bd4365bd%7D\/low-dose-hcg-can-prevent-sterility-in-men-prescribed-testosterone"},{"key":"cit0039","unstructured":"US National Library of Medicine. Clinicaltrials.gov. A study to evaluate the effect of testosterone replacement therapy (TRT) on the incidence of major adverse cardiovascular events (MACE) and efficacy measures in hypogonadal men (TRAVERSE). [cited 2019 Nov 04]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03518034"},{"key":"cit0040","unstructured":"Healio Endocrine Today (online). FDA approves oral testosterone capsule for men with hypogonadism. 2019 Mar 27 [cited 2019 Nov 04]. Available from: https:\/\/www.healio.com\/endocrinology\/reproduction-androgen-disorders\/news\/online\/%7Be9ea0fe9-a419-415f-a335-a43d81758b04%7D\/fda-approves-oral-testosterone-capsule-for-men-with-hypogonadism"},{"issue":"9","key":"cit0041","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1210\/js.2019-00183","volume":"3","author":"Gronski MA","year":"2019","journal-title":"J Endocr Soc"},{"key":"cit0042","unstructured":"Bosworth T. First RCT with aromatase inhibitor for male hypogonadism shows promise. MDEdge (online); 2019 Mar 29 [cited 2019 Nov 04]. Available from: https:\/\/www.mdedge.com\/endocrinology\/article\/197821\/mens-health\/first-rct-aromatase-inhibitor-male-hypogonadism-shows"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2019.1612239"}],"container-title":["Expert Review of Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17446651.2020.1773259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T10:07:10Z","timestamp":1620468430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17446651.2020.1773259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7,3]]}},"alternative-id":["10.1080\/17446651.2020.1773259"],"URL":"https:\/\/doi.org\/10.1080\/17446651.2020.1773259","relation":{},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}